Strategy (MSTR) shares plunged approximately 45% over the last 30 days, falling from $159.09 on May 29 to $86.93 on June 30, as Bitcoin's decline below $60,000 triggered a severe repricing of the leveraged Bitcoin proxy. The company's market capitalization fell below the value of its 847,363 Bitcoin holdings for the first time, with the mNAV ratio dropping to approximately 0.99, eroding investor confidence in the long-running cryptocurrency treasury strategy.

Accenture shares tumbled approximately 36.7% over the last 30 days, driven primarily by a disappointing fiscal third-quarter earnings report and reduced full-year revenue guidance. The stock suffered its worst single-day decline on record on June 18, 2026, plunging roughly 18-20% after the company trimmed its FY2026 growth outlook.

CME Group shares fell approximately 14.3% over the last 30 days, dropping from $257.76 on June 1, 2026, to $220.88 as of June 30, 2026. The selloff was driven by a confluence of factors including the announced CEO succession plan, regulatory approval of competing perpetual futures products, and a new equity-index futures competitor entering the market.

Palantir Technologies (PLTR) shares fell approximately 25.5% over the last 30 days, sliding from $156.54 on May 29 to $116.62 on June 30, 2026. The sell-off was driven by a combination of European contract setbacks, valuation compression across the software sector, and a high-profile short position from investor Michael Burry.

Progress Software reported Q2 2026 revenue of $253.47 million, up 6.79% year-over-year and ahead of consensus estimates. Adjusted earnings per share reached $1.62, surpassing analyst expectations by $0.13.

Constellation Brands reported first quarter fiscal 2027 net sales of $2.43 billion, slightly above consensus estimates. Adjusted earnings per share came in at $3.43, beating analyst expectations of approximately $3.21 to $3.27.

NIKE reported fourth-quarter revenue of $11.0 billion, down 1% on a reported basis and 4% on a currency-neutral basis from the prior year. Diluted earnings per share reached $0.72, including a $0.52 benefit from expected IEEPA tariff recoveries, well above consensus estimates around $0.12-$0.13.

GLW shares rose approximately 22% over the past 30 days, advancing from a closing price near $181 in late May 2026 to around $221 by late June 2026. The advance reflects sustained investor enthusiasm for Corning’s exposure to AI infrastructure and data-center connectivity.

CRM shares declined approximately 17% over the past 30 days, falling from closing levels near 191 in late May 2026 to 157.93 on June 29, 2026. The broader quarterly trend shows continued pressure, with the stock trading well below earlier 2026 highs amid sector rotation and valuation concerns.

AT&T Inc. (T) stock declined approximately 8% over the past 30 days, lagging broader market gains amid telecom sector rotation and pre-earnings caution.

INTC shares rose approximately 15% over the past 30 days, climbing from a closing price near $114.68 on May 29, 2026, to $131.72 on June 29, 2026. The stock showed strong momentum within a broader quarterly recovery, with year-to-date gains exceeding 240% as of late June 2026.

KLAC shares rose more than 11% over the past 30 days, driven by strong semiconductor sector momentum and AI-related demand. The company reported solid quarterly results earlier in the period, with robust orders in its core inspection and metrology businesses.

SAP SE maintains a dominant position in enterprise resource planning and cloud software solutions, with ongoing emphasis on AI-driven enhancements across its product suite. Recent stock performance has shown relative stability amid broader technology sector dynamics, supported by consistent demand for digital transformation initiatives.

GE Vernova shares have gained approximately 7.9% over the past 30 days, reflecting sustained investor confidence in the company's central role in AI-driven energy demand. The stock has surged roughly 27.6% over the last quarter, supported by a record $163 billion backlog and strong Q1 2026 earnings that beat analyst expectations.

UNCY shares tumbled -34.22% on Tuesday, falling from a previous close of $7.13 to $4.69, after the FDA issued a second Complete Response Letter for its kidney disease drug candidate oxylanthanum carbonate. The selloff ignited in premarket trading and intensified during the regular session, with intraday losses briefly exceeding -46% before a partial recovery into the close.

CAT shares rose approximately 18% over the past 30 days, driven primarily by strong demand for power generation equipment tied to data center expansion. The stock reached an all-time high above $1,050 before moderating, reflecting investor enthusiasm for infrastructure and energy-related growth.

CRCL tumbled -13.59% during Tuesday's regular session, dropping from a prior close of $75.96 to $65.64, as heavy selling overwhelmed the stock. The primary catalyst was CRCL's removal from five major Russell Growth Indexes in the annual reconstitution, forcing passive funds and index-linked mandates to liquidate positions.

HTFL shares tumbled -14.25% during Tuesday's regular session, falling from Friday's close of $35.65 to $30.57, as heavy selling pressure continued following the June 26 disclosure of CEO John Farquhar's $1.36 million insider stock sale. The CEO sold 38,900 shares at $35.00 on June 24 under a pre-arranged Rule 10b5-1 trading plan, a move that rattled investor confidence and triggered a sharp reassessment of the company's near-term prospects.

SOC shares crashed -42.61% to $4.00 during regular trading on June 30, following the company's announcement of a $400 million dilutive securities offering. The proposed offering includes $100 million in common stock and $300 million in convertible senior notes due 2031, triggering severe dilution concerns for existing shareholders.

BLD shares tumbled -15.45% during the June 29 regular session, closing at $359.76 after shareholders voted to approve the acquisition by QXO Holdings. The sell-off was driven by the final cash/stock election results, which implied a lower effective merger consideration than the initially announced $505 per share.